Regulation of prostaglandin synthesis in the human uterus

References

• Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79:1193–226
   PubMed Web of Science ®Google Scholar
• Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LBA, Lipsky PE. Cyclooxygenase in biology and disease. FASEB J 1998;12:1063–73
   PubMed Web of Science ®Google Scholar
• Okazaki T, Casey ML, Okita JR, MacDonald PC, Johnston JM. Initiation of human parturition. XII. Biosynthesis and metabolism of prostaglandins in human fetalmembranes and uterine decidua. AmJObstet Gynecol 1981;139:373–81
   Google Scholar
• Skinner KA, Challis JR. Changes in the synthesis and metabolism of prostaglandins by human fetal membranes and decidua at labor. Am J Obstet Gynecol 1985;151:519–23
   PubMed Web of Science ®Google Scholar
• Rees MC,Di Marzo V, Lopez BernalA,Tippins JR,Morris HR, Trunbull AC. Leukotriene release by human fetal membranes, placenta and decidua in relation to parturition. J Endocrinol 1988;118:497–500
   Google Scholar
• Thiery M. Induction of labor with prostaglandins. In Keirse MJN, ed. Human Parturition. The Hague/Boston/ London: Martinus Nijhoff Publishers, 1979
   Google Scholar
• Lewis RB, Schulman JD. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 1973;2:1159–61
   PubMed Web of Science ®Google Scholar
• Gamissans O, Canas E, Cararach V, Ribas J, Puerto B, Edo A. A study of indomethacin combined with ritodrine in threatened preterm labor. Eur JObstetGynecol Reprod Biol 1978;8:123–8
   Google Scholar
• Salmon JA, Amy J-J. Levels of prostaglandin F2 alpha in amniotic fluid during pregnancy and labour. Prostaglandins 1973;4:523–33
   Google Scholar
• Dray F, Frydman R. Primary prostaglandins in amniotic fluid in pregnancy and spontaneous labor. Am J Obstet Gynecol 1976;126:13–19
   PubMed Web of Science ®Google Scholar
• Nieder J, Augustin W. Increase of prostaglandin E and F equivalents in amniotic fluid during late pregnancy and rapid PG F elevation after cervical dilatation. Prostaglandins Leukotrienes Med 1983;12:289–97
   PubMedGoogle Scholar
• Romero R, Baumann P, Gonzalez R, Gomez R, Rittenhouse L, Behnke E, Mitchell MD. Amniotic fluid prostanoid concentrations increase early during the course of spontaneous labor at term. Am J Obstet Gynecol 1994;171:1613–20
   PubMed Web of Science ®Google Scholar
• Hertelendy F,Woods R, Jaffe BM. Prostaglandin E levels in peripheral blood during labor. Prostaglandins 1973; 3:223–7
   Google Scholar
• Satoh K, Yasumizu T, Fukuoka H, Kinoshita K, Kaneko Y, Tsuchiya M, Sakamoto S. Prostaglandin F2 alphametabolite levels in plasma, amniotic fluid, and urine during pregnancy and labor. Am J Obstet Gynecol 1979;133:886–90
   Google Scholar
• Casey ML, MacDonald PC. Human parturition: distinction between the initiation of parturition and the onset of labor. Semin Reprod Endocrinol 1993;11:272–84
   Google Scholar
• MacDonald PC, Casey ML. The accumulation of prostaglandins (PG) in amniotic fluid is an aftereffect of labor and not indicative of a role for PGE2 or PGF2 alpha in the initiation of human parturition. J Clin Endocrinol Metab 1993;76:1332–9
   PubMed Web of Science ®Google Scholar
• Romero R, Munoz H, Gomez R, Parra M, Polanco M, Valverde V, Hasbun J, Garrido J, Ghezzi F, Mazor M, Tolosa JE, Mitchell MD. Increase in prostaglandin bioavailability precedes the onset of human parturition [published erratum appears in Prostaglandins Leukotrienes Essent Fatty Acids 1996;55:458]. Prostaglandins Leukotrienes Essent Fatty Acids 1996;54:187–91
   PubMed Web of Science ®Google Scholar
• Smith WL, Marnett LJ, DeWitt DL. Prostaglandin and thromboxane biosynthesis. Pharmacol Ther 1991;49:153–79
   PubMedGoogle Scholar
• Sangha RK, Walton JC, Ensor CM, Tai HH, Challis JR. Immunohistochemical localization, mRNA abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placental and fetalmembranes during term and preterm labor. J Clin Endocrinol Metab 1994;78:982–9
   Google Scholar
• Van Meir CA, Ramirez MM, Matthews SG, Calder AA, Kierse MJ, Challis JR. Chorionic prostaglandin catabolism is decreased in the lower uterine segment with term labour. Placenta 1997;18:109–14
   PubMed Web of Science ®Google Scholar
• Okita JR, Johnston JM, MacDonald PC. Source of prostaglandin precursor in human fetal membranes: arachidonic acid content of amnion and chorion laeve in diamnionicdichorionic twin placentas. Am J Obstet Gynecol 1983; 147:477–82
   Google Scholar
• Lopez Bernal A, Newman GE, Phizackerley PJ, Turnbull AC. Surfactant stimulates prostaglandin E production in human amnion. Br J Obstet Gynaecol 1988;95:1013–17
   Google Scholar
• Newman GE, Phizackerley PJ, Lopez BernalA.Utilization by human amniocytes for prostaglandin synthesis of [1–14C]arachidonate derived from 2–[1–14C]arachidonylphosphatidylcholine associated with human fetal pulmonary surfactant. Biochim Biophys Acta 1993;1176:106–12
   Google Scholar
• Bernal AL, Phizackerley PJ. Fetal surfactant as a source of arachidonate in human amniotic fluid. Prostaglandins Other Lipid Mediat 2000;60:59–70
   Google Scholar
• Keirse MJ, Hicks BR, Mitchell MD, Turnbull AC. Increase of the prostaglandin precursor, arachidonic acid, in amniotic fluid during spontaneous labour. Br J Obstet Gynaecol 1977;84:937–40
   Google Scholar
• Schwarz BE, Schultz FM, Macdonald PC, Johnston JM. Initiation of human parturition. III. Fetal membrane content of prostaglandin E2 and F2alpha precursor. Obstet Gynecol 1975;46:564–8
   PubMedGoogle Scholar
• Curbelo V, Bejar R, Benirschke K, Gluck L. Premature labor. I. Prostaglandin precursors in human placental membranes. Obstet Gynecol 1981;57:473–8
   Google Scholar
• Okita JR, MacDonald PC, Johnston JM. Mobilization of arachidonic acid from specific glycerophospholipids of human fetal membranes during early labor. J Biol Chem 1982;257:14029–34
   Google Scholar
• Olson DM,Smieja Z.Arachidonic acid incorporation into lipids of term human amnion. Am J Obstet Gynecol 1988; 159:995–1001
   Google Scholar
• Rose MP, Myatt L, Elder MG. Pathways of arachidonic acid metabolism in human amnion cells at term. Prostaglandins Leukotrienes Essent Fatty Acids 1990;39:303–9
   Google Scholar
• Schultz FM, Schwarz BE, MacDonald PC, Johnston JM. Initiation of human parturition. II. Identification of phospholipase A2 in fetal chorioamnion and uterine decidua. Am J Obstet Gynecol 1975;123:650–3
   Google Scholar
• Grieves SA, Liggins GC. Phospholipase A activity in human and ovine uterine tissues. Prostaglandins 1976;12:229–41
   Google Scholar
• Okazaki T, Okita JR, MacDonald PC, Johnston JM. Initiation of human parturition. X. Substrate specificity of phospholipase A2 in human fetalmembranes. AmJObstet Gynecol 1978;130:432–8
   Google Scholar
• Okazaki T, SagawaN, Bleasdale JE,Okita JR, MacDonald PC, Johnston JM. Initiation of human parturition: XIII. Phospholipase C, phospholipase A2, and diacylglycerol lipase activities in fetal membranes and decidua vera tissues from early and late gestation. Biol Reprod 1981;25:103–9
   Google Scholar
• Aitken MA, Rice GE, Brennecke SP. Gestational tissue phospholipase A2 messenger RNA content and the onset of spontaneous labour in the human. Reprod Fertil Dev 1990;2:575–80
   PubMedGoogle Scholar
• Aitken MA, RiceG, Brennecke S. Relative abundance of human placental phospholipase A2 messenger RNA in late pregnancy. Prostaglandins 1992;43:361–70
   PubMedGoogle Scholar
• Aitken MA, Farrugia W, Wong MH, Scott KF, Brennecke SP, Rice GE. Type II phospholipase A2 in human gestational tissues: extractable immuno- and enzymatic activity in fetal membranes. Biochim Biophys Acta 1993;1170:314–20
   PubMedGoogle Scholar
• Rice GE,Wong MH, Farrugia W, Scott KF. Contribution of type II phospholipase A2 to in vitro phospholipase A2 enzymatic activity in human term placenta. J Endocrinol 1998;157:25–31
   Google Scholar
• Johansen B, Rakkestad K, Balboa MA, Dennis EA. Expression of cytosolic and secreted forms of phospholipase A(2) and cyclooxygenases in human placenta, fetal membranes, and chorionic cell lines. Prostaglandins Other Lipid Mediat 2000;60:119–25
   PubMed Web of Science ®Google Scholar
• Suzuki N, Ishizaki J, Yokota Y, Higashino K,Ono T, Ikeda M, Fujii N, Kawamoto K, Hanasaki K. Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A(2)s. J Biol Chem 2000;275:5785–93
   PubMed Web of Science ®Google Scholar
• Moses EK, Freed KA, Brennecke SP, Rice GE. Distribution of the phospholipase A2 receptor messenger RNA in human gestational tissues. Placenta 1998;19:35–40
   Google Scholar
• Freed KA, Moses EK, Brennecke SP, RiceGE.Differential expression of type II, IV and cytosolic PLA2 messenger RNA in human intrauterine tissues at term. Mol Hum Reprod 1997;3:493–9
   Google Scholar
• Skannal DG, Brockman DE, Eis AL, Xue S, Siddiqi TA, Myatt L. Changes in activity of cytosolic phospholipase A2 in human amnion at parturition. Am J Obstet Gynecol 1997;177:179–84
   PubMed Web of Science ®Google Scholar
• Skannal DG, Eis AL, Brockman D, Siddiqi TA, Myatt L. Immunohistochemical localization of phospholipase A2 isoforms in human myometrium during pregnancy and parturition. Am J Obstet Gynecol 1997;176:878–82
   PubMed Web of Science ®Google Scholar
• Munns MJ, FarrugiaW,King RG,Rice GE. Secretory type II PLA2 immunoreactivity and PLA2 enzymatic activity in human gestational tissues before, during and after spontaneous-onset labour at term. Placenta 1999;20:21–6
   Google Scholar
• Leslie CC. Properties and regulation of cytosolic phospholipase A2. J Biol Chem 1997;272:16709–12
   PubMed Web of Science ®Google Scholar
• Di Renzo GC, Johnston JM, Okazaki T, Okita JR, MacDonald PC, Bleasdale JE. Phosphatidylinositolspecific phospholipase C in fetal membranes and uterine decidua. J Clin Invest 1981;67:847–56
   Google Scholar
• Okita JR, MacDonald PC, Johnston JM. Initiation of human parturition XIV. Increase in the diacylglycerol content of amnion during parturition. Am J Obstet Gynecol 1982;142:432–5
   PubMedGoogle Scholar
• Bala GA, Thakur NR, Bleasdale JE. Characterization of the major phosphoinositide-specific phospholipase C of human amnion. Biol Reprod 1990;43:704–11
   PubMed Web of Science ®Google Scholar
• Rhee SG, Bae YS. Regulation of phosphoinositidespecific phospholipase C isoenzymes. J Biol Chem 1997; 272:15045–8
   PubMed Web of Science ®Google Scholar
• Balboa MA, Balsinde J, Dennis EA. Involvement of phosphatidate phosphohydrolase in arachidonic acid mobilization in human amnionic WISH cells. J Biol Chem 1998;273:7684–90
   Google Scholar
• Inamori K, Sagawa N, Hasegawa M, Itoh H, Uede H, Kobayashi F, Ihara Y, Mori T. Identification and partial characterization of phospholipase D in the human amniotic membrane. Biochem Biophys Res Commun 1993;191:1270–7
   Google Scholar
• Ikebuchi Y, Masumoto N,Tasaka K, Koike K, Kasahara K, Miyake A, Tanizawa O. Superoxide anion increases intracellular pH, intracellular free calcium, and arachidonate release in human amnion cells. J Biol Chem 1991;266:13233–7
   PubMedGoogle Scholar
• Potestio FA, Olson DM. Arachidonic acid release from cultured human amnion cells: the effect of dexamethasone. J Clin Endocrinol Metab 1990;70:647–54.
   Google Scholar
• Moore JJ, Dubyak GR, Moore RM, Vander Kooy D. Oxytocin activates the inositol–phospholipid–protein kinase-C system and stimulates prostaglandin production in human amnion cells. Endocrinology 1988;123:1771–7
   Google Scholar
• Vander Kooy D, Dubyak GR, Moore RM, Moore JJ. Adenosine triphosphate activates the phospholipase-C cascade system in human amnion cells without increasing prostaglandin production. Endocrinology 1989;124:2005–12
   Google Scholar
• Bennett PR, Slater D, Sullivan M, Elder MG, Moore GE. Changes in amniotic arachidonic acid metabolism associated with increased cyclo-oxygenase gene expression. Br J Obstet Gynaecol 1993;100:1037–42
   Google Scholar
• Nguyen HT, Rice GE, Farrugia W, Wong M, Brennecke SP. Bacterial endotoxin increases type II phospholipase A2 immunoreactive content and phospholipase A2 enzymatic activity in human choriodecidua. Biol Reprod 1994;50:526–34
   Google Scholar
• Farrugia W, Nicholls L, Rice GE. Effect of bacterial endotoxin on the in vitro release of type II phospholipase- A2 and prostaglandin E2 from human placenta. J Endocrinol 1999;160:291–6
   Google Scholar
• Schrey MP, Holt JR, Cornford PA, Monaghan H, al-Ubaidi F. Human decidua is a target tissue for bradykinin and kallikrein: phosphoinositide hydrolysis accompanies arachidonic acid release in uterine decidua cells in vitro. J Clin Endocrinol Metab 1992;74:426–35
   Google Scholar
• Rehbock J, Chondromatidou A, Buchinger P, Hermann A. The B2 receptor on cultured human decidua cells: release of arachidonic acid by bradykinin. Immunopharmacology 1996;33:164–6
   Google Scholar
• Molnár M, Romero R, Hertelendy F. Interleukin-1 and tumor necrosis factor stimulate arachidonic acid release and phospholipid metabolism in humanmyometrial cells. Am J Obstet Gynecol 1993;169:825–9
   PubMed Web of Science ®Google Scholar
• Hertelendy F,Molnár M, Rigó J Jr. Proposed signaling role of arachidonic acid in human myometrium. Mol Cell Endocrinol 1995;110:113–18
   Google Scholar
• Brown NL, Alvi SA, Elder MG, Bennett PR, Sullivan MHF. Regulation of prostaglandin production in intact fetal membranes by interleukin-1 and its receptor antagonist. J Endocrinol 1998;159:519–26
   PubMed Web of Science ®Google Scholar
• Xue S, Brockman DE, Slater DM, Myatt L. Interleukin-1 beta induces the synthesis and activity of cytosolic phospholipase A2 and the release of prostaglandin E2 in human amnion-derived WISH cells. Prostaglandins 1995; 49:351–69
   Google Scholar
• Xue S, SlaterDM, Bennett PR, Myatt L. Induction of both cytosolic phospholipase A2 and prostaglandin H synthase-2 by interleukin-1 beta in WISH cells is inhibited by dexamethasone. Prostaglandins 1996;51:107–24
   PubMedGoogle Scholar
• Hansen WR, Drew A, Helsby N, Keelan JA, Sato TA, Mitchell MD. Regulation of cytosolic phospholipase A2 expression by cytokines in human amnion cells. Placenta 1999;20:303–8
   Google Scholar
• Herschman HR. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev 1994; 13:241–56
   PubMed Web of Science ®Google Scholar
• Goppelt-Struebe M. Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression. Prostaglandins Leukotrienes Essent Fatty Acids 1995;52:213–22
   PubMed Web of Science ®Google Scholar
• Gaffney RC, Rice GE, Brennecke SP. Is human labour triggered by an increase in the rate of synthesis of prostaglandin G/H synthase? Reprod Fertil Dev 1990;2:603–6
   Google Scholar
• Teixeira FJ, Zakar T, Hirst JJ, Guo F, Sadowsky DW, Machin G, Demianczuk N, Resch B, Olson DM. Prostaglandin endoperoxide-H synthase (PGHS) activity and immunoreactive PGHS-1 and PGHS-2 levels in human amnion throughout gestation, at term, and during labor. J Clin Endocrinol Metab 1994;78:1396–402
   PubMed Web of Science ®Google Scholar
• Mijovic JE, Zakar T, Nairn TK, Olson DM. Prostaglandin-endoperoxide H synthase-2 expression and activity increaseswith term labor in human chorion. Am J Physiol 1997;272:E832–40
   Google Scholar
• Mijovic JE, Zakar T, Nairn TK, Olson DM. Prostaglandin endoperoxide H synthase (PGHS) activity and PGHS-1 and -2 messenger ribonucleic acid abundance in human chorion throughout gestation and with preterm labor. J Clin Endocrinol Metab 1998;83:1358–67
   Google Scholar
• Hirst JJ, Mijovic JE, Zakar T, Olson DM. Prostaglandin endoperoxide H synthase-1 and -2 mRNA levels and enzyme activity in human decidua at term labor. J Soc Gynecol Invest 1998;5:13–20
   Google Scholar
• Mijovic JE, Zakar T, Angelova J, Olson DM. Prostaglandin endoperoxide H synthase mRNA expression in the human amnion and decidua during pregnancy and in the amnion at preterm labour. MolHum Reprod 1999;5:182–7
   Google Scholar
• Slater D, Dennes W, Sawdy R, Allport V, Bennett P. Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy. J Mol Endocrinol 1999;22:125–30
   PubMed Web of Science ®Google Scholar
• Slater DM, BergerLC,Newton R, MooreGE, Bennett PR. Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term. AmJObstetGynecol 1995;172:77–82
   PubMed Web of Science ®Google Scholar
• Slater D, Allport V, Bennett P. Changes in the expression of the type-2 but not the type-1 cyclo-oxygenase enzyme in chorion–decidua with the onset of labour. Br J Obstet Gynaecol 1998;105:745–8
   PubMedGoogle Scholar
• Hirst JJ, Teixeira FJ, Zakar T, Olson DM. Prostaglandin endoperoxide-H synthase-1 and -2 messenger ribonucleic acid levels in human amnion with spontaneous labor onset. J Clin Endocrinol Metab 1995;80:517–23
   PubMed Web of Science ®Google Scholar
• Macchia L, Di Paola R, GuerreseMC, Chiechi LM, Tursi A, Caiaffa MF, Haeggstrom JZ. Expression of prostaglandin endoperoxide H synthase 1 and 2 in human placenta at term. Biochem Biophys Res Commun 1997;233:496–501
   PubMed Web of Science ®Google Scholar
• Fuentes A, Spaziani EP, O’Brien WF. The expression of cyclooxygenase-2 (COX-2) in amnion and decidua following spontaneous labor. Prostaglandins 1996;52:261–7
   PubMed Web of Science ®Google Scholar
• Sadovsky Y, NelsonDM, Muglia LJ,GrossGA,HarrisKC, Koki A, Masferrer JL, Olson LM. Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2. Am J Obstet Gynecol 2000; 182:370–6
   Google Scholar
• Sawdy RJ, Slater DM, Dennes WJ, Sullivan MH, Bennett PR. The roles of the cyclo-oxygenases types one and two in prostaglandin synthesis in human fetal membranes at term. Placenta 2000;21:54–7
   PubMed Web of Science ®Google Scholar
• Zuo J, Lei ZM, Rao CV, Pietrantoni M, Cook VD. Differential cyclooxygenase-1 and -2 gene expression in human myometria from preterm and term deliveries. J Clin Endocrinol Metab 1994;79:894–9
   Google Scholar
• Moore SD, Brodt-Eppley J, Cornelison LM, Burk SE, Slater DM, Myatt L. Expression of prostaglandin H synthase isoforms in human myometrium at parturition. Am J Obstet Gynecol 1999;180:103–9
   Google Scholar
• Slater DM, DennesWJ, Campa JS, Poston L, Bennett PR. Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy. Mol Hum Reprod1999;5:880–4
   Google Scholar
• Sparey C, Robson SC, Bailey J, Lyall F, Europe-Finner GN. The differential expression of myometrial connexin-43, cyclooxygenase-1 and -2, and Gs alpha proteins in the upper and lower segments of the human uterus during pregnancy and labor. J Clin Endocrinol Metab1999;84:1705–10
   Google Scholar
• Erkinheimo T-L, Saukkonen K, Narko K, Jalkanen J, Ylikorkala O, Ristimäki A. Expression of cyclooxygenase2 and prostanoid receptors by human myometrium. J Clin Endocrinol Metab 2000;85:3468–75
   Google Scholar
• Romero R, Emamian M, Wan M, Quintero R, Hobbins JC, Mitchell MD. Prostaglandin concentrations in amniotic fluid of women with intra-amniotic infection and preterm labor. AmJObstetGynecol1987;157:1461–7
   Google Scholar
• Romero R, Wu YK, Sirtori M, Oyarzun E, Mazor M, Hobbins JC, Mitchell MD. Amniotic fluid concentration of prostaglandin F2 alpha, 13,14-dihydro- 15-ketoprostaglandin F2 alpha (PGFM) and 11-deoxy-13, 14-dihydro-15-keto-11, 16-cyclo-prostaglandin E2 (PGEM-LL) in preterm labor. Prostaglandins 1989;37:149–61
   PubMed Web of Science ®Google Scholar
• Lopez Bernal A, Hansell DJ, Khong TY, Keeling JW, Turnbull AC. Prostaglandin E production by the fetal membranes in unexplained preterm labour and preterm labour associated with chorioamnionitis. Br J Obstet Gynaecol 1989;96:1133–9
   Google Scholar
• Mitchell MD, Edwin SS, Lundin-Schiller S, Silver RM, Smotkin D, Trautman MS. Mechanism of interleukin-1 beta stimulation of human amnion prostaglandin biosynthesis: mediation via a novel inducible cyclooxygenase. Placenta 1993;14:615–25
   PubMed Web of Science ®Google Scholar
• Albert TJ, Su HC, Zimmerman PD, Iams JD, Kniss DA. Interleukin-1 beta regulates the inducible cyclooxygenase in amnion-derived WISH cells. Prostaglandins 1994;48:401–16
   Google Scholar
• Trautman MS, Edwin SS, Collmer D, Dudley DJ, Simmons D, MitchellMD. Prostaglandin H synthase-2 in human gestational tissues: regulation in amnion. Placenta 1996;17:239–45
   Web of Science ®Google Scholar
• Hulkower KI,Otis ER, Li J, Ennis BW,CugierDJ, Bell RL, Carter GW, Glaser KB. Induction of prostaglandin H synthase-2 and tumor necrosis factor-alpha in human amnionic WISH cells by various stimuli occurs through distinct intracellular mechanisms. J Pharmacol Exp Ther 1997;280:1065–74
   Google Scholar
• Hansen WR, Sato T, Mitchell MD. Tumour necrosis factor-alpha stimulates increased expression of prostaglandin endoperoxide H synthase Type 2 mRNA in amnion-derived WISH cells. J Mol Endocrinol 1998; 20:221–31
   Google Scholar
• Belt AR, Baldassare JJ,MolnárM, Romero R, Hertelendy F. The nuclear transcription factor NF-kappaB mediates interleukin-1beta-induced expression of cyclooxygenase- 2 in human myometrial cells. Am J ObstetGynecol 1999;181:359–66
   PubMed Web of Science ®Google Scholar
• Pomini F, Caruso A, Challis JR. Interleukin-10 modifies the effects of interleukin-1beta and tumor necrosis factor-alpha on the activity and expression of prostaglandin H synthase-2 and the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase in cultured term human villous trophoblast and chorion trophoblast cells. J Clin Endocrinol Metab 1999;84:4645–51
   PubMed Web of Science ®Google Scholar
• Wang Z, Tai HH. Interleukin-1 beta and dexamethasone regulate gene expression of prostaglandin Hsynthase-2 via the NF-kB pathway in human amnion derived WISH cells. Prostaglandins Leukotrienes Essent Fatty Acids 1998;59:63–9
   Google Scholar
• Allport VC, Slater DM, Newton R, Bennett PR. NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod 2000;6:561–5
   PubMedGoogle Scholar
• Belt AR, Baldassare JJ, Romero R, Hertelendy F. IL-1 activates the MAP kinase family of enzymes in human myometrial cells: evidence for the involvement of p38 kinase in IL-1-induced cyclooxygenase-2 (Cox-2) expression. J Soc Gynecol Invest 1998;5(Suppl):64A
   Google Scholar
• Bartlett SR, Sawdy R, Mann GE. Induction of cyclooxygenase- 2 expression in human myometrial smooth muscle cells by interleukin-1b: involvement of p38 mitogen-activated protein kinase. J Physiol 1999;520:399–406
   Google Scholar
• Anteby EY, Johnson RD, Huang X, Dryden DK, Nelson DM, Sadovsky Y. Lipopolysaccharide enhances the transcription of prostaglandin H synthase-2 gene in primary human trophoblasts. Am J Obstet Gynecol 1998; 178:469–73.
   PubMed Web of Science ®Google Scholar
• Gilmour JS,Hansen WR, Miller HC,Keelan JA, Sato TA, Mitchell MD. Effects of interleukin-4 on the expression and activity of prostaglandin endoperoxide H synthase-2 in amnion-derived WISH cells. J Mol Endocrinol 1998;21:317–25
   Web of Science ®Google Scholar
• Keelan JA, SatoTA,HansenWR, Gilmour JS,Gupta DK, Helsby NA, Mitchell MD. Interleukin-4 differentially regulates prostaglandin production in amnion-derived WISH cells stimulated with pro-inflammatory cytokines and epidermal growth factor. Prostaglandins Leukotrienes Essent Fatty Acids 1999;60:255–62
   Google Scholar
• Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta 1996;1299:125–40
   PubMed Web of Science ®Google Scholar
• Perkins DJ, Kniss DA. Rapid and transient induction of cyclo-oxygenase 2 by epidermal growth factor in human amnion-derived WISHcells. Biochem J 1997;321:677–81
   PubMedGoogle Scholar
• Riley SC,Greer IA, Schembri LA, Challis JR. Dexamethasone inhibits basal and stimulated prostaglandin E2 output from human placental cells by inhibition of prostaglandin H synthase. Gynecol Obstet Invest 1992;33:85–9
   Google Scholar
• Gibb W, Lavoie JC. Effects of glucocorticoids on prostaglandin formation by human amnion. Can J Physiol Pharmacol 1990;68:671–6
   PubMed Web of Science ®Google Scholar
• Mitchell MD, Lytton FD, Varticovski L. Paradoxical stimulation of both lipocortin and prostaglandin production in human amnion cells by dexamethasone. Biochem Biophys Res Commun 1988;151:137–41
   PubMed Web of Science ®Google Scholar
• Potestio FA, Zakar T, Olson DM. Glucocorticoids stimulate prostaglandin synthesis in human amnion cells by a receptor-mediated mechanism. J Clin Endocrinol Metab 1988;67:1205–10
   PubMed Web of Science ®Google Scholar
• Zakar T, Hirst JJ, Mijovic JE, Olson DM. Glucocorticoids stimulate the expression of prostaglandin endoperoxide H synthase-2 in amnion cells. Endocrinology 1995;136:1610–19
   PubMed Web of Science ®Google Scholar
• Economopoulos P, Sun M, Purgina B, Gibb W. Glucocorticoids stimulate prostaglandin H synthase type-2 (PGHS-2) in the fibroblast cells in human amnion cultures. Mol Cell Endocrinol 1996;117:141–7
   PubMed Web of Science ®Google Scholar
• Blumenstein M, Hansen WR, Deval D, Mitchell MD. Differential regulation in human amnion epithelial and fibroblast cells of prostaglandin E(2) production and prostaglandin H synthase-2 mRNA expression by dexamethasone but not tumour necrosis factor-alpha. Placenta 2000;21:210–17
   Google Scholar
• Whittle WL, Gibb W, Challis JR. The characterization of human amnion epithelial and mesenchymal cells: the cellular expression, activity and glucocorticoid regulation of prostaglandin output. Placenta 2000;21:394–401
   PubMed Web of Science ®Google Scholar
• Zakar T, Mijovic JE, Eyster KM, Bhardwaj D, Olson DM. Regulation of prostaglandin H2 synthase-2 expression in primary human amnion cells by tyrosine kinase dependent mechanisms. Biochim Biophys Acta 1998;1391:37–51
   Google Scholar
• Johnson CA, Balboa MA, Balsinde J, Dennis EA. Regulation of cyclooxygenase-2 expression by phosphatidate phosphohydrolase in human amnionic WISH cells. J Biol Chem 1999;274:27689–93
   Google Scholar
• Molnár M, Rigó J Jr, Romero R, Hertelendy F. Oxytocin activates mitogen-activated protein kinase and upregulates cyclooxygenase-2 and prostaglandin production in human myometrial cells. Am J Obstet Gynecol 1999; 181:42–9
   PubMed Web of Science ®Google Scholar
• Anteby EY, Johnson RD,Huang X,NelsonDM, Sadovsky Y. Transcriptional regulation of prostaglandin-H synthase-2 gene in human trophoblasts. J Clin Endocrinol Metab 1997;82:2289–93
   Google Scholar
• Lundgren DW, Moore RM, Collins PL, Moore JJ. Hypotonic stress increases cyclooxygenase-2 expression and prostaglandin release from amnion-derived WISH cells. J Biol Chem 1997;272:20118–24
   Google Scholar
• Kobayashi H, Sun GW, Terao T. Production of prostanoids via increased cyclooxygenase-2 expression in human amnion cells in response to low molecular weight hyaluronic acid fragment. Biochim Biophys Acta 1998; 1425:369–76
   Google Scholar
• Zakar T, Mijovic JE, Bhardwaj D, Olson DM. Tyrosine kinase inhibitors block the glucocorticoid stimulation of prostaglandin endoperoxide H synthase expression in amnion cells. Can J Physiol Pharmacol 1999;77:138–42
   PubMed Web of Science ®Google Scholar
• Brown NL, Alvi SA, Elder MG, Bennett PR, Sullivan MH. A spontaneous induction of fetal membrane prostaglandin production precedes clinical labour. J Endocrinol 1998;157:R1–6
   Google Scholar
• Alvi SA, Brown NL, Bennett PR, Elder MG, Sullivan MH. Corticotrophin-releasing hormone and plateletactivating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. Mol Hum Reprod 1999;5:476–80
   PubMedGoogle Scholar
• Romero R, Wu YK,Mazor M, Hobbins JC, MitchellMD. Amniotic fluid prostaglandin E2 in preterm labor. Prostaglandins Leukotrienes Essent Fatty Acids 1988;34:141–5
   PubMed Web of Science ®Google Scholar
• Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999;94:869–77
   PubMed Web of Science ®Google Scholar
• Leguizamón G, Smith J, Younis H, Nelson DM, Sadovsky Y. Enhancement of amniotic cyclooxygenase type 2 activity in women with preterm delivery associated with twins or polyhydramnios. Am J Obstet Gynecol 2001;184:117–22
   PubMedGoogle Scholar
• Gibb W, Sun M. Localization of prostaglandin H synthase type 2 protein and mRNA in term human fetal membranes and decidua. J Endocrinol 1996;150:497–503
   PubMed Web of Science ®Google Scholar
• Sugimoto Y, Yamasaki A, Segi E, Tsuboi K, Aze Y, Nishimura T, Oida H, Yoshida N, Tanaka T, Katsuyama M,Hasumoto K, Murata T,Hirata M, Ushikubi F,Negishi M, IchikawaA,Narumiya S. Failure of parturition inmice lacking the prostaglandin F receptor. Science 1997; 277:681–3
   PubMed Web of Science ®Google Scholar